Trials / Completed
CompletedNCT01963312
Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.
A Randomised Clinical Trial to Compare Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate Compared Versus the Transurethral Resection of the Prostate to Treat the Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Fundacion Miguel Servet · Academic / Other
- Sex
- Male
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the transarterial supraselective embolization (TSE) is a technique as effective as transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).
Conditions
- Transurethral Resection of Prostate
- Artery Embolization
- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transarterial Supraselective Embolization of the prostate | |
| PROCEDURE | Transurethral Resection of the prostate |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2018-04-01
- Completion
- 2018-05-01
- First posted
- 2013-10-16
- Last updated
- 2018-05-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01963312. Inclusion in this directory is not an endorsement.